Association between mitral valve prolapse and other regurgitant valvular lesions in a 37,705 echocardiogram database

D. Paniagua, H. R. Aldrich, G. A. Lamas, E. H. Lieberman, A. S. Agatston

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to identify an association between mitral valve prolapse (MVP) and régurgitation in other cardiac valves. 37,705 consecutive patients who underwent echocardiography at Mount Sinai Medical Center between 1987-1994 were screened for inclusion in this study. MVP was identified in 2783 patients (7.4%). Patients with confounding conditions which could also cause valvular régurgitation such as left ventricular (LV) dysfunction, mitral annular calcification, pulmonary hypertension, pericardial effijsion, and LV hypertrophy were excluded from the study (n=1317). Patients with MVP (n=1366) were compared to an age-sex matched control population (n=1366). The mean age in each group was 56±20 years . The percentage of females was 58.3% in each group There was no difference in LV ejection fraction between the MVP (59.5%±4) and control group (59.2%±5). Aortic régurgitation (AR) occurred more frequently in the MVP group (18%) than the control group (13%) (p < 0.001). The percentage of patients with moderate to severe tricuspid régurgitation (TR) was greater in the MVP group (21%) than the control population (10%) (p <0.0001). The incidence of combined AR and MR was also significantly higher in the MVP group (14%) than the control population (6%) (p<0.0001). MVP is a common finding which is associated with other régurgitant valvular lesions. In a subgroup of patients in this database, there may be a common etiology for MVP, TR, and AR.

Original languageEnglish
JournalJournal of Investigative Medicine
Volume44
Issue number3
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Mitral Valve Prolapse
Databases
Control Groups
Echocardiography
Population
Heart Valves
Left Ventricular Dysfunction
Left Ventricular Hypertrophy
Pulmonary Hypertension
Stroke Volume

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Association between mitral valve prolapse and other regurgitant valvular lesions in a 37,705 echocardiogram database. / Paniagua, D.; Aldrich, H. R.; Lamas, G. A.; Lieberman, E. H.; Agatston, A. S.

In: Journal of Investigative Medicine, Vol. 44, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

Paniagua, D. ; Aldrich, H. R. ; Lamas, G. A. ; Lieberman, E. H. ; Agatston, A. S. / Association between mitral valve prolapse and other regurgitant valvular lesions in a 37,705 echocardiogram database. In: Journal of Investigative Medicine. 1996 ; Vol. 44, No. 3.
@article{028c96e4d2994c1c98925d2c549a5287,
title = "Association between mitral valve prolapse and other regurgitant valvular lesions in a 37,705 echocardiogram database",
abstract = "The purpose of this study was to identify an association between mitral valve prolapse (MVP) and r{\'e}gurgitation in other cardiac valves. 37,705 consecutive patients who underwent echocardiography at Mount Sinai Medical Center between 1987-1994 were screened for inclusion in this study. MVP was identified in 2783 patients (7.4{\%}). Patients with confounding conditions which could also cause valvular r{\'e}gurgitation such as left ventricular (LV) dysfunction, mitral annular calcification, pulmonary hypertension, pericardial effijsion, and LV hypertrophy were excluded from the study (n=1317). Patients with MVP (n=1366) were compared to an age-sex matched control population (n=1366). The mean age in each group was 56±20 years . The percentage of females was 58.3{\%} in each group There was no difference in LV ejection fraction between the MVP (59.5{\%}±4) and control group (59.2{\%}±5). Aortic r{\'e}gurgitation (AR) occurred more frequently in the MVP group (18{\%}) than the control group (13{\%}) (p < 0.001). The percentage of patients with moderate to severe tricuspid r{\'e}gurgitation (TR) was greater in the MVP group (21{\%}) than the control population (10{\%}) (p <0.0001). The incidence of combined AR and MR was also significantly higher in the MVP group (14{\%}) than the control population (6{\%}) (p<0.0001). MVP is a common finding which is associated with other r{\'e}gurgitant valvular lesions. In a subgroup of patients in this database, there may be a common etiology for MVP, TR, and AR.",
author = "D. Paniagua and Aldrich, {H. R.} and Lamas, {G. A.} and Lieberman, {E. H.} and Agatston, {A. S.}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "44",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Association between mitral valve prolapse and other regurgitant valvular lesions in a 37,705 echocardiogram database

AU - Paniagua, D.

AU - Aldrich, H. R.

AU - Lamas, G. A.

AU - Lieberman, E. H.

AU - Agatston, A. S.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - The purpose of this study was to identify an association between mitral valve prolapse (MVP) and régurgitation in other cardiac valves. 37,705 consecutive patients who underwent echocardiography at Mount Sinai Medical Center between 1987-1994 were screened for inclusion in this study. MVP was identified in 2783 patients (7.4%). Patients with confounding conditions which could also cause valvular régurgitation such as left ventricular (LV) dysfunction, mitral annular calcification, pulmonary hypertension, pericardial effijsion, and LV hypertrophy were excluded from the study (n=1317). Patients with MVP (n=1366) were compared to an age-sex matched control population (n=1366). The mean age in each group was 56±20 years . The percentage of females was 58.3% in each group There was no difference in LV ejection fraction between the MVP (59.5%±4) and control group (59.2%±5). Aortic régurgitation (AR) occurred more frequently in the MVP group (18%) than the control group (13%) (p < 0.001). The percentage of patients with moderate to severe tricuspid régurgitation (TR) was greater in the MVP group (21%) than the control population (10%) (p <0.0001). The incidence of combined AR and MR was also significantly higher in the MVP group (14%) than the control population (6%) (p<0.0001). MVP is a common finding which is associated with other régurgitant valvular lesions. In a subgroup of patients in this database, there may be a common etiology for MVP, TR, and AR.

AB - The purpose of this study was to identify an association between mitral valve prolapse (MVP) and régurgitation in other cardiac valves. 37,705 consecutive patients who underwent echocardiography at Mount Sinai Medical Center between 1987-1994 were screened for inclusion in this study. MVP was identified in 2783 patients (7.4%). Patients with confounding conditions which could also cause valvular régurgitation such as left ventricular (LV) dysfunction, mitral annular calcification, pulmonary hypertension, pericardial effijsion, and LV hypertrophy were excluded from the study (n=1317). Patients with MVP (n=1366) were compared to an age-sex matched control population (n=1366). The mean age in each group was 56±20 years . The percentage of females was 58.3% in each group There was no difference in LV ejection fraction between the MVP (59.5%±4) and control group (59.2%±5). Aortic régurgitation (AR) occurred more frequently in the MVP group (18%) than the control group (13%) (p < 0.001). The percentage of patients with moderate to severe tricuspid régurgitation (TR) was greater in the MVP group (21%) than the control population (10%) (p <0.0001). The incidence of combined AR and MR was also significantly higher in the MVP group (14%) than the control population (6%) (p<0.0001). MVP is a common finding which is associated with other régurgitant valvular lesions. In a subgroup of patients in this database, there may be a common etiology for MVP, TR, and AR.

UR - http://www.scopus.com/inward/record.url?scp=33749446632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749446632&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749446632

VL - 44

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 3

ER -